Celsius (NASDAQ:CELH) Stock Price Expected to Rise, Needham & Company LLC Analyst Says

Celsius (NASDAQ:CELH - Get Free Report) had its price objective increased by analysts at Needham & Company LLC from $47.00 to $55.00 in a research report issued to clients and investors on Thursday, MarketBeat.com reports. The firm presently has a "buy" rating on the stock. Needham & Company LLC's price objective would indicate a potential upside of 21.74% from the stock's previous close.

Several other brokerages also recently weighed in on CELH. Piper Sandler lifted their target price on shares of Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a report on Wednesday, June 4th. Truist Financial boosted their target price on shares of Celsius from $45.00 to $50.00 and gave the company a "buy" rating in a research note on Friday, June 6th. Wells Fargo & Company increased their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Stifel Nicolaus started coverage on shares of Celsius in a report on Thursday, June 12th. They issued a "buy" rating and a $47.00 price target on the stock. Finally, LADENBURG THALM/SH SH dropped their target price on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, Celsius has an average rating of "Moderate Buy" and an average target price of $45.65.

Celsius Trading Down 2.0%

CELH traded down $0.92 during trading hours on Thursday, hitting $45.18. 4,262,084 shares of the company's stock were exchanged, compared to its average volume of 8,115,235. Celsius has a 12-month low of $21.10 and a 12-month high of $60.70. The firm has a 50 day moving average of $40.53 and a 200 day moving average of $33.29. The firm has a market cap of $11.64 billion, a P/E ratio of 76.83, a price-to-earnings-growth ratio of 1.64 and a beta of 1.45.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). The company had revenue of $329.28 million for the quarter, compared to analyst estimates of $349.09 million. Celsius had a return on equity of 42.12% and a net margin of 8.40%. The firm's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.27 EPS. As a group, research analysts expect that Celsius will post 0.89 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, major shareholder William H. Milmoe sold 300,000 shares of the stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $47.27, for a total transaction of $14,181,000.00. Following the sale, the insider owned 18,017,770 shares in the company, valued at $851,699,987.90. This represents a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO John Fieldly sold 130,803 shares of the business's stock in a transaction that occurred on Tuesday, June 24th. The shares were sold at an average price of $45.00, for a total value of $5,886,135.00. Following the transaction, the chief executive officer owned 1,038,577 shares of the company's stock, valued at $46,735,965. This represents a 11.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 562,974 shares of company stock worth $25,758,418 over the last three months. 2.55% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of CELH. Alliancebernstein L.P. grew its holdings in shares of Celsius by 26.3% in the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock worth $642,769,000 after acquiring an additional 3,753,055 shares during the last quarter. Champlain Investment Partners LLC bought a new position in shares of Celsius during the 4th quarter valued at $85,068,000. Contrarius Group Holdings Ltd acquired a new position in shares of Celsius during the 4th quarter valued at about $75,535,000. Norges Bank bought a new position in shares of Celsius in the fourth quarter valued at approximately $72,579,000. Finally, Alyeska Investment Group L.P. raised its holdings in Celsius by 60.5% in the 4th quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock worth $181,164,000 after acquiring an additional 2,591,345 shares during the period. Institutional investors own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.